Chemoinformaics analysis of 4-(3-hydroxy-1-propenyl)-2-methoxy
Molecular Weight | 180.203 | nRot | 3 |
Heavy Atom Molecular Weight | 168.107 | nRig | 7 |
Exact Molecular Weight | 180.079 | nRing | 1 |
Solubility: LogS | -1.146 | nHRing | 0 |
Solubility: LogP | 1.248 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
nHA | 3 | APOL | 27.1075 |
nHD | 2 | BPOL | 13.7745 |
QED | 0.739 |
Synth | 2.093 |
Natural Product Likeliness | 1.532 |
NR-PPAR-gamma | 0.011 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.321 |
HIA | 0.01 |
CACO-2 | -4.457 |
MDCK | 0.000018 |
BBB | 0.295 |
PPB | 0.807399 |
VDSS | 1.059 |
FU | 0.169568 |
CYP1A2-inh | 0.709 |
CYP1A2-sub | 0.867 |
CYP2c19-inh | 0.042 |
CYP2c19-sub | 0.422 |
CYP2c9-inh | 0.032 |
CYP2c9-sub | 0.836 |
CYP2d6-inh | 0.019 |
CYP2d6-sub | 0.893 |
CYP3a4-inh | 0.087 |
CYP3a4-sub | 0.241 |
CL | 12.341 |
T12 | 0.92 |
hERG | 0.035 |
Ames | 0.141 |
ROA | 0.386 |
SkinSen | 0.949 |
Carcinogencity | 0.662 |
EI | 0.987 |
Respiratory | 0.502 |
NR-Aromatase | 0.08 |
Antiviral | No |
Prediction | 0.874965 |